IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 316 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,642 | -83.2% | 896 | -84.8% | 0.00% | -87.5% |
| Q2 2023 | $241,584 | +44637.8% | 5,888 | -61.1% | 0.01% | -52.9% |
| Q1 2023 | $540 | +96.4% | 15,119 | +107.9% | 0.02% | +54.5% |
| Q4 2022 | $275 | -99.9% | 7,272 | -38.1% | 0.01% | +37.5% |
| Q3 2022 | $520,000 | +881.1% | 11,755 | +722.0% | 0.01% | +700.0% |
| Q2 2022 | $53,000 | -83.6% | 1,430 | -83.6% | 0.00% | -66.7% |
| Q1 2022 | $323,000 | +773.0% | 8,728 | +611.9% | 0.00% | +200.0% |
| Q4 2021 | $37,000 | +37.0% | 1,226 | +54.2% | 0.00% | 0.0% |
| Q3 2021 | $27,000 | -93.3% | 795 | -92.2% | 0.00% | -90.9% |
| Q2 2021 | $406,000 | -26.7% | 10,183 | -17.4% | 0.01% | +22.2% |
| Q1 2021 | $554,000 | -42.2% | 12,323 | -27.3% | 0.01% | -69.0% |
| Q4 2020 | $958,000 | +13.5% | 16,943 | -4.8% | 0.03% | +222.2% |
| Q3 2020 | $844,000 | +2457.6% | 17,795 | +3153.2% | 0.01% | +800.0% |
| Q2 2020 | $33,000 | -90.7% | 547 | -92.7% | 0.00% | -95.5% |
| Q1 2020 | $354,000 | +6980.0% | 7,482 | +8914.5% | 0.02% | – |
| Q3 2019 | $5,000 | -95.8% | 83 | -95.5% | 0.00% | -100.0% |
| Q2 2019 | $119,000 | +5850.0% | 1,852 | +4773.7% | 0.01% | – |
| Q4 2018 | $2,000 | -97.8% | 38 | -97.9% | 0.00% | -100.0% |
| Q3 2018 | $93,000 | +210.0% | 1,805 | +147.3% | 0.01% | +250.0% |
| Q2 2018 | $30,000 | -93.4% | 730 | -92.9% | 0.00% | -94.9% |
| Q1 2018 | $455,000 | +1200.0% | 10,321 | +1424.5% | 0.04% | +875.0% |
| Q2 2017 | $35,000 | +400.0% | 677 | +289.1% | 0.00% | +300.0% |
| Q1 2017 | $7,000 | -92.5% | 174 | -91.1% | 0.00% | -90.0% |
| Q4 2016 | $93,000 | +1228.6% | 1,962 | +906.2% | 0.01% | +900.0% |
| Q3 2016 | $7,000 | -65.0% | 195 | -77.1% | 0.00% | -50.0% |
| Q2 2016 | $20,000 | +900.0% | 850 | +1973.2% | 0.00% | – |
| Q1 2016 | $2,000 | -91.7% | 41 | -89.4% | 0.00% | -100.0% |
| Q4 2015 | $24,000 | – | 385 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |